CASEIN HYDROLYSATE
    1.
    发明申请
    CASEIN HYDROLYSATE 审中-公开
    CASEIN水解产物

    公开(公告)号:US20170037442A1

    公开(公告)日:2017-02-09

    申请号:US14876413

    申请日:2015-10-06

    Abstract: A casein hydrolysate formed by controlled hydrolysis of a casein substrate by an aspergillus-derived (fugal) proteolytic preparation is described. The controlled hydrolysis employs a FlavorPro-Whey™ formulation and a degree of hydrolysis (% DH) of from 5% DH to 15% DH. The Hydrolysate has at least a 98% reduction in antigenicity compared to intact sodium caseinate and a mean bitterness score of less than 30%. The invention also provides a low molecular weight fraction of casein hydrolysate of the invention which is substantially free of peptides having a molecular weight greater than 5 kDa.

    Abstract translation: 描述了通过曲霉衍生(矮化)蛋白水解制剂对酪蛋白底物的可控水解形成的酪蛋白水解产物。 受控的水解使用FlavorPro-Whey TM制剂和5%DH至15%DH的水解度(%DH)。 与完整的酪蛋白酸钠相比,水解产物的抗原性降低至少98%,平均苦味评分低于30%。 本发明还提供本发明的酪蛋白水解产物的低分子量级分,其基本上不含分子量大于5kDa的肽。

    CASEIN HYDROLYSATE
    2.
    发明申请
    CASEIN HYDROLYSATE 审中-公开
    CASEIN水解产物

    公开(公告)号:US20140213762A1

    公开(公告)日:2014-07-31

    申请号:US13985321

    申请日:2012-02-17

    Abstract: A casein hydrolysate formed by controlled hydrolysis of a casein substrate by an aspergillus-derived (fugal) proteolytic preparation is described. The controlled hydrolysis employs a FlavorPro-Whey™ formulation and a degree of hydrolysis (% DH) of from 5% DH to 15% DH. The hydrolysate has at least a 98% reduction in antigenicity compared to intact sodium caseinate and a mean bitterness score of less than 30%. The invention also provides a low molecular weight fraction of a casein hydrolysate of the invention which is substantially free of peptides having a molecular weight greater than 5 kDa

    Abstract translation: 描述了通过曲霉衍生(矮化)蛋白水解制剂对酪蛋白底物的可控水解形成的酪蛋白水解产物。 受控的水解使用FlavorPro-Whey TM制剂和5%DH至15%DH的水解度(%DH)。 与完整的酪蛋白酸钠相比,水解产物的抗原性降低至少98%,平均苦味评分小于30%。 本发明还提供了本发明的酪蛋白水解产物的低分子量级分,其基本上不含分子量大于5kDa的肽

    PROTEIN PRODUCT FOR MODIFYING CARDIOVASCULAR HEALTH
    4.
    发明申请
    PROTEIN PRODUCT FOR MODIFYING CARDIOVASCULAR HEALTH 审中-公开
    用于改善心血管健康的蛋白产品

    公开(公告)号:US20110130637A1

    公开(公告)日:2011-06-02

    申请号:US12933533

    申请日:2009-03-19

    CPC classification number: A61K38/018

    Abstract: A composition for use in the treatment or prophylaxis of conditions mediated by endothelial function in mammals is provided. The composition includes a milk protein hydrolysate generated by treating milk or milk whey protein with a proteolytic enzyme having subtilisin or subtilisin-like activity and/or glutamyl endopeptidase or glutamyl endopeptidase-like activity. The composition is useful in the management of vascular conditions.

    Abstract translation: 提供了用于治疗或预防哺乳动物内皮功能介导的病症的组合物。 该组合物包括通过用具有枯草杆菌蛋白酶或枯草杆菌蛋白酶样活性的蛋白水解酶和/或谷氨酰内肽酶或谷氨酰肽内肽酶活性来处理乳或乳清蛋白产生的乳蛋白水解产物。 该组合物可用于管理血管病症。

Patent Agency Ranking